患者からの異種移植を用いたクリアセル腎臓細胞癌の血清タンパク質バイオマーカーの特定
Dalin Zhang1, Chun-Lung Chiu1,2, Fernando Jose Garcia Marques3,4
1Department of Urology, Stanford University School of Medicine, Stanford, California, USA.
The Journal of clinical investigation
|January 2, 2026
まとめ
No abstract available in PubMed .
さらに関連する動画
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.7K
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
14.1K
